C12Y 301/27004
Ribonuclease u2
Official title: Ribonuclease U2 (3.1.27.4)
C12Y301/27004 (Ribonuclease u2) appears on 5 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 7
- Assignees
- 5
- Inventors
- 6
- Latest grant
- 3 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Biomarkers for the early detection of breast cancer3 Feb 2026US 12,540,940 B2Arizona Board of Regents
- Biomarkers for the early detection of breast cancer11 Apr 2023US 11,624,747 B2Arizona Board of Regents
- RNA affinity purification12 Jul 2022US 11,384,352 B2ModernaTX, Inc.
- Biomarkers for the early detection of breast cancer13 Oct 2020US 10,802,026 B2Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University
- Biomarkers for the early detection of breast cancer2 Jan 2018US 9,857,374 B2Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University
- Biomarkers for the early detection of breast cancer14 May 2026US 2026/0133199 A1President and Fellows of Harvard College
- Biomarkers for the early detection of breast cancer3 Aug 2023US 2023/0243829 A1Arizona Board of Regents
- Rna affinity purification15 Sep 2022US 2022/0290125 A1ModernaTX, Inc.
- Biomarkers for the early detection of breast cancer24 Dec 2020US 2020/0400671 A1President and Fellows of Harvard College
- Rna affinity purification5 Mar 2020US 2020/0071689 A1ModernaTX, Inc.
Most cited
By later US patents
- RNA affinity purification45US 11,384,352 B2ModernaTX, Inc. · 2022
- Biomarkers for the early detection of breast cancer19US 9,857,374 B2Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University · 2018
- Biomarkers for the early detection of breast cancer3US 10,802,026 B2Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University · 2020